The C12orf43 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for functional investigation of the C12orf43 gene. This gene-edited product provides a pooled population of HAP1 cells carrying diverse disruptions in the target locus, enabling loss-of-function studies without clonal selection artifacts. By introducing targeted gene disruptions via CRISPR/Cas9, this polyclonal knockout model serves as a reliable tool for exploring the biological significance of C12orf43 in a high-throughput-compatible format.
The HAP1 cell line is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia (CML) cell line. HAP1 exhibits a mostly haploid karyotype (except for a disomic chromosome 8 region) and displays a fibroblast-like morphology. Originating from a male donor, these adherent cells retain features of the leukemic lineage while offering a genetically simplified background. The haploid nature reduces genetic redundancy, making HAP1 particularly advantageous for knockout-based functional genomics and drug-target validation studies.
C12orf43 is a putative protein-coding gene whose biological function remains largely uncharacterized. To date, no specific upstream regulators, downstream targets, or interacting partners have been experimentally validated, and it has not been assigned to any well-defined signaling pathway. The encoded protein’s subcellular localization, domain architecture, and functional roles are yet to be elucidated. CRISPR/Cas9-mediated disruption of C12orf43 in a defined genetic background provides a powerful loss-of-function model to investigate its potential involvement in cellular processes such as proliferation, survival, or differentiation.
The C12orf43 knockout in the HAP1 haploid genetic model offers distinct advantages for genetic perturbation studies. The near-haploid nature facilitates efficient gene disruption and reduces off-target concerns, while the leukemic origin provides a disease-relevant context for exploring potential roles in cancer biology. Combined with polyclonal knockout generation, this system allows researchers to assess the functional consequences of C12orf43 loss across a heterogeneous cell population, capturing a range of mutation-induced phenotypes. This model is suited for both arrayed and pooled screening formats, enabling the dissection of gene function in a high-throughput manner.
Typical applications include functional genomics screens, phenotypic profiling, gene characterization, and drug target validation. Researchers can employ a variety of downstream assays such as cell viability and proliferation assays, transcriptomic analysis via RNA-seq, proteomic profiling, and drug sensitivity testing to uncover the role of C12orf43. This polyclonal knockout product is an essential resource for laboratories seeking to decipher the biological function of C12orf43 and its potential relevance in disease. For additional technical details or to place an order, please contact Ascent Research.
